Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 52 articles: HTML format

Single Articles

September 2025
1. ANDO Y, Uedo N, Tani Y, Ueda T, et al
   Usefulness of Underwater Endoscopic Mucosal Resection Compared With Conventional Endoscopic Mucosal Resection for Early Gastric Cancer.
   J Gastroenterol Hepatol. 2025 Sep 3. doi: 10.1111/jgh.70062.
   PubMed     Abstract available
   
   
   
2. ISHIDA T, Yamaguchi T, Yoshida T, Kobayashi S, et al
   Evaluating Malignant Potential of Gastric Adenomas: The Role of Endoscopic Features and Genetic Alterations.
   J Gastroenterol Hepatol. 2025;40:2282-2289.
   PubMed     Abstract available
   
   
   August 2025
3. JEON HJ, Choi HS, Lee JM, Kim ES, et al
   Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study.
   J Gastroenterol Hepatol. 2025 Aug 7. doi: 10.1111/jgh.70000.
   PubMed     Abstract available
   
   
   
4. IWASAKI M, Matsumura T, Okimoto K, Ohyama Y, et al
   Long-Term Outcomes of Gastric Subepithelial Lesion of < 2 cm and Risk Factors for Tumor Growth.
   J Gastroenterol Hepatol. 2025;40:1926-1932.
   PubMed     Abstract available
   
   
   July 2025
5. WAJEEHA FNU, Raza S, Toor Z
   Comments on Programmed Cell Death Signature and THBS1 in Gastric Cancer: Advancing Toward Translational Clarity.
   J Gastroenterol Hepatol. 2025 Jul 24. doi: 10.1111/jgh.70035.
   PubMed    
   
   
   June 2025
6. WANG J, Li D, Ye F, Li J, et al
   Global Epidemiology of Early-Onset Digestive System Malignancy: A Systematic Analysis for the Global Burden of Disease Study 2021.
   J Gastroenterol Hepatol. 2025;40:1525-1535.
   PubMed     Abstract available
   
   
   
7. ALI M, Srour L, Bitar M, Karam K, et al
   Current Guidelines and Advances in the Management of Fundic Gland Polyps.
   J Gastroenterol Hepatol. 2025;40:1374-1380.
   PubMed     Abstract available
   
   
   
8. XIE X, Su J, Wang W, Wei H, et al
   Trends in Stomach Cancer Burden in China: A Joinpoint and APC Analysis Based on GBD 2021.
   J Gastroenterol Hepatol. 2025;40:1500-1514.
   PubMed     Abstract available
   
   
   May 2025
9. SHIBATA H, Fujiyoshi T, Kawata N, Obayashi T, et al
   Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents.
   J Gastroenterol Hepatol. 2025 May 27. doi: 10.1111/jgh.17027.
   PubMed     Abstract available
   
   
   
10. YOUNG E, Wan N, Philpott H, Singh R, et al
    The West Catching Up With the East: High-Magnification NBI Is Accurate for the Diagnosis of Gastric Neoplasia in a Western Population.
    J Gastroenterol Hepatol. 2025;40:1128-1134.
    PubMed     Abstract available
    
    
    April 2025
11. WANG M, Guo Y, Xu Y, Yu Y, et al
    Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response.
    J Gastroenterol Hepatol. 2025 Apr 28. doi: 10.1111/jgh.16987.
    PubMed     Abstract available
    
    
    
12. PITTAYANON R, Tiankanon K, Faknak N, Lerttanatum N, et al
    Efficacy of Radiofrequency Ablation as a Treatment for High-Risk Gastric Intestinal Metaplasia: A Randomized, Self-Control Study.
    J Gastroenterol Hepatol. 2025;40:891-899.
    PubMed     Abstract available
    
    
    March 2025
13. 
    NOTIFICATION: MiR-876-3p Regulates Cisplatin Resistance and Stem Cell-like Properties of Gastric Cancer Cells by Targeting TMED3.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16919.
    PubMed    
    
    
    February 2025
14. HARA K, Kawara F, Yamanaka K, Nishioka C, et al
    Gastrointestinal: White Granules in the Stomach Caused by Lymphangitis Carcinomatosis From Signet-Ring Cell Gastric Carcinoma.
    J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1111/jgh.16894.
    PubMed    
    
    
    December 2024
15. HUANG L, Feng B, Yang Z, Feng ST, et al
    A Transfer Learning Radiomics Nomogram to Predict the Postoperative Recurrence of Advanced Gastric Cancer.
    J Gastroenterol Hepatol. 2024 Dec 27. doi: 10.1111/jgh.16863.
    PubMed     Abstract available
    
    
    
16. OTANI K, Hang DV, Pittayanon R, Liu H, et al
    Asia-Pacific Survey on the Management of Helicobacter pylori Infection.
    J Gastroenterol Hepatol. 2024 Dec 26. doi: 10.1111/jgh.16862.
    PubMed     Abstract available
    
    
    
17. MATSUEDA K, Kono Y, Miyahara K, Nakagawa M, et al
    Clinical Significance of Lymphatic Involvement in Intramucosal (pT1a) Gastric Cancer Resected by Endoscopic Submucosal Dissection.
    J Gastroenterol Hepatol. 2024 Dec 18. doi: 10.1111/jgh.16854.
    PubMed     Abstract available
    
    
    
18. PAKNESHAN S, Moy N, Shah A, Koloski N, et al
    Post-colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study.
    J Gastroenterol Hepatol. 2024;39:2811-2816.
    PubMed     Abstract available
    
    
    
19. HUANG L, Xu M, Li Y, Dong Z, et al
    Gastric neoplasm detection of computer-aided detection-assisted esophagogastroduodenoscopy changes with implement scenarios: a real-world study.
    J Gastroenterol Hepatol. 2024;39:2787-2795.
    PubMed     Abstract available
    
    
    
20. HIRATA S, Hamada K, Iwamuro M, Mouri H, et al
    Rates and risk factors of bleeding after gastric endoscopic submucosal dissection with continuous warfarin or 1-day withdrawal of direct oral anticoagulants.
    J Gastroenterol Hepatol. 2024;39:2760-2766.
    PubMed     Abstract available
    
    
    September 2024
21. DANPANICHKUL P, Auttapracha T, Kongarin S, Ponvilawan B, et al
    Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019.
    J Gastroenterol Hepatol. 2024;39:1856-1868.
    PubMed     Abstract available
    
    
    August 2024
22. ISHIBASHI F, Suzuki S, Kobayashi K, Tanaka R, et al
    Cost-effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16715.
    PubMed     Abstract available
    
    
    
23. HAYASAKA J, Hoteya S, Takazawa Y, Kikuchi D, et al
    Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.
    J Gastroenterol Hepatol. 2024;39:1580-1585.
    PubMed     Abstract available
    
    
    July 2024
24. CHANTAROJANASIRI T, Sonthalia N, Lui RN
    Small gastric subepithelial lesions: A sand in the eye.
    J Gastroenterol Hepatol. 2024;39:1207-1209.
    PubMed    
    
    
    
25. GENG ZH, Qu YF, Fu PY, Zhu Y, et al
    A scoring system to predict the technical difficulty of endoscopic resection for cardial submucosal tumors.
    J Gastroenterol Hepatol. 2024;39:1352-1357.
    PubMed     Abstract available
    
    
    
26. MIMURA T, Yamamoto Y, Suzuki H, Takizawa K, et al
    Risk factors for intraoperative and delayed perforation related with gastric endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2024;39:1358-1366.
    PubMed     Abstract available
    
    
    
27. FUJITA M, Yamaguchi K, Nagashima K, Suzuki K, et al
    Impact of the COVID-19 pandemic on gastric surgery in Japan: A nationwide study using interrupted time-series analyses.
    J Gastroenterol Hepatol. 2024;39:1277-1284.
    PubMed     Abstract available
    
    
    
28. KOBAYASHI R, Hirasawa K, Ozeki Y, Sawada A, et al
    Clinical course of small gastric subepithelial lesion less than 20 mm diagnosed by endoscopic ultrasound-guided fine-needle aspiration.
    J Gastroenterol Hepatol. 2024;39:1285-1290.
    PubMed     Abstract available
    
    
    
29. ZENG X, Yang L, Dong Z, Gong D, et al
    The effect of incorporating domain knowledge with deep learning in identifying benign and malignant gastric whitish lesions: A retrospective study.
    J Gastroenterol Hepatol. 2024;39:1343-1351.
    PubMed     Abstract available
    
    
    June 2024
30. LI M, He W, Wang F, Zhang P, et al
    High expression of NOTCH2 in gastric adenocarcinoma: A novel early diagnostic target.
    J Gastroenterol Hepatol. 2024;39:1115-1122.
    PubMed     Abstract available
    
    
    
31. CHEUNG KS
    Big data approach in the field of gastric and colorectal cancer research.
    J Gastroenterol Hepatol. 2024;39:1027-1032.
    PubMed     Abstract available
    
    
    
32. CHEN L, Jin T, Fang Y, Wu G, et al
    Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    J Gastroenterol Hepatol. 2024;39:1073-1081.
    PubMed     Abstract available
    
    
    May 2024
33. KAWAMURA M, Uedo N, Yao K, Koike T, et al
    Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    J Gastroenterol Hepatol. 2024 May 13. doi: 10.1111/jgh.16617.
    PubMed     Abstract available
    
    
    
34. CHO JH, Jin SY, Park S
    Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
    J Gastroenterol Hepatol. 2024;39:942-948.
    PubMed     Abstract available
    
    
    
35. TANI Y, Li JW, Uedo N
    Gastrointestinal: Texture and color enhancement imaging is useful for detection of small gastric adenocarcinoma of fundic-gland type.
    J Gastroenterol Hepatol. 2024;39:783-784.
    PubMed    
    
    
    April 2024
36. ASONUMA S, Hatta W, Koike T, Okata H, et al
    Risk stratification of synchronous gastric cancers including alcohol-related genetic polymorphisms.
    J Gastroenterol Hepatol. 2024 Apr 16. doi: 10.1111/jgh.16570.
    PubMed     Abstract available
    
    
    
37. ZHAN ZQ, Chen YZ, Huang ZM, Luo YH, et al
    Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
    J Gastroenterol Hepatol. 2024;39:630-641.
    PubMed     Abstract available
    
    
    
38. WANG Z, He D, Yang JL
    Gastrointestinal: Chronic anemia caused by diffuse lesions of the stomach.
    J Gastroenterol Hepatol. 2024;39:615-616.
    PubMed    
    
    
    March 2024
39. GU L, Wang X, Ouyang M, Li F, et al
    Facilitating endoscopic full-thickness resection for gastric submucosal tumors with a novel snare traction method (with video).
    J Gastroenterol Hepatol. 2024;39:535-543.
    PubMed     Abstract available
    
    
    November 2023
40. DONG X, Chen X, Zhao Y, Wu Q, et al
    CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
    J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1111/jgh.16402.
    PubMed     Abstract available
    
    
    
41. TANAKA K, Baba Y
    Gastrointestinal: Diminutive Epstein-Barr virus-associated gastric carcinoma.
    J Gastroenterol Hepatol. 2023 Nov 16. doi: 10.1111/jgh.16410.
    PubMed    
    
    
    October 2023
42. MATSUEDA K, Uedo N, Kitamura M, Shichijo S, et al
    Endoscopic features of gastric neuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2023;38:1808-1817.
    PubMed     Abstract available
    
    
    
43. JUNG YS, Tran MTX, Park B, Moon CM, et al
    Mutual association between family history of gastric and colorectal cancer and risk of gastric and colorectal cancer.
    J Gastroenterol Hepatol. 2023;38:1787-1793.
    PubMed     Abstract available
    
    
    September 2023
44. QUEK SXZ, Lee JWJ, Feng Z, Soh MM, et al
    Comparing artificial intelligence to humans for endoscopic diagnosis of gastric neoplasia: An external validation study.
    J Gastroenterol Hepatol. 2023;38:1587-1591.
    PubMed     Abstract available
    
    
    August 2023
45. ZHANG P, Xu T, Wang J, Li Y, et al
    Comparison of different risk stratifications for gastric cancer and establishing a simplified risk-scoring model based on the Kyoto classification.
    J Gastroenterol Hepatol. 2023 Aug 24. doi: 10.1111/jgh.16324.
    PubMed     Abstract available
    
    
    June 2023
46. KAWASAKI K, Torisu T, Esaki M, Eizuka M, et al
    Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesions: A propensity score matched study.
    J Gastroenterol Hepatol. 2023;38:955-961.
    PubMed     Abstract available
    
    
    
47. LIU J, Xiang Y, Tang D, Xu G, et al
    Gastrointestinal: A case of type 1 gastric neuroendocrine tumor with multiple endocrine neoplasia type 1.
    J Gastroenterol Hepatol. 2023;38:842.
    PubMed    
    
    
    May 2023
48. TANAKA T, Miwa K, Shimotsuura Y, Nagasu S, et al
    High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
    J Gastroenterol Hepatol. 2023 May 24. doi: 10.1111/jgh.16239.
    PubMed     Abstract available
    
    
    
49. HIGASHINO M, Ono S, Matsumoto S, Kubo M, et al
    Improvement of detection sensitivity of upper gastrointestinal epithelial neoplasia in linked color imaging based on data of eye tracking.
    J Gastroenterol Hepatol. 2023;38:710-715.
    PubMed     Abstract available
    
    
    April 2023
50. CHEN N, Hu Y, Huang RZ, Chen DL, et al
    Circular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by regulating ZEB2.
    J Gastroenterol Hepatol. 2023 Apr 20. doi: 10.1111/jgh.16189.
    PubMed     Abstract available
    
    
    March 2023
51. NIE X, Zhao C, Zhang Y, Huang W, et al
    Nucleolar protein TCOF1 maintains gastric cancer cell proliferation by regulating R-loop associated DNA replication stress.
    J Gastroenterol Hepatol. 2023 Mar 20. doi: 10.1111/jgh.16181.
    PubMed     Abstract available
    
    
    
52. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.